News AGRI-TECH

AgPlenus advances AI-driven fungicide research with 75 per cent reduction in wheat disease

The Evogene subsidiary reports progress in two fungicide discovery programmes targeting resistant Septoria strains, with selected compounds demonstrating promising activity against additional fungal pathogens
November 18, 2026 | 0 Comments
Image Source: Public Domain
Image Source: Public Domain

AgPlenus, a subsidiary of Israeli biotechnology company Evogene, has reported progress in two fungicide discovery programmes targeting Septoria tritici blotch, a major disease affecting wheat production worldwide. Using its ChemPass AI for Ag platform, the company identified compounds targeting previously unexplored fungal proteins, with selected molecules reducing disease by 75 per cent in plant tissue assays.

Septoria tritici blotch, caused by Zymoseptoria tritici, is responsible for substantial wheat yield losses and remains a major challenge for growers, particularly in Europe. Increasing resistance to established fungicides, including succinate dehydrogenase inhibitors (SDHIs), has intensified the search for crop protection products with alternative modes of action.

According to AgPlenus, more than 70 per cent of fungicide use in European wheat production has historically been directed towards Septoria management, representing an estimated market opportunity of approximately €1.2 billion.

AI-driven discovery targets fungicide resistance

AgPlenus is developing fungicide candidates that act on previously untapped proteins essential for fungal survival. The approach is intended to identify new mechanisms of disease control that could help address resistance to existing fungicide classes.

Through its ChemPass AI for Ag discovery platform, which integrates artificial intelligence, predictive biology and computational chemistry, the company identified small molecules capable of inhibiting their intended fungal targets.

The compounds demonstrated fungicidal activity against Septoria strains, including those resistant to existing treatments. Selected compounds reduced disease by 75 per cent in plant tissue assays, while certain biological findings were independently corroborated by an external research organisation.

The company said these results support the continued development of both discovery programmes.

Potential applications beyond Septoria

AgPlenus also reported that some compounds demonstrated activity against additional fungal pathogens, suggesting potential applications beyond wheat Septoria management.

The findings will guide further molecular optimisation and biological evaluation as the company works towards identifying potential fungicide development candidates.

Orli Even Or, Vice President of Research and Development at AgPlenus, said the progress reflects the importance of developing new fungicide modes of action to address increasing resistance in crop protection.

The company aims to use its AI-driven discovery platform to accelerate the identification and optimisation of compounds targeting previously unexplored biological mechanisms.

However, the research remains at the discovery and early evaluation stage. Further testing, including field efficacy, crop safety and regulatory assessments, will be required before any resulting fungicide can advance towards commercialisation.

The latest findings build on AgPlenus' ongoing efforts to develop differentiated crop protection molecules and expand the potential applications of AI-assisted agricultural chemical discovery.

Share This Article With Your Network

Leave a Reply

Your email address will not be published.

Your session has expired. Please Sign-in or Sign-up
New User? Create Account

Country Focus

View More